Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

U.S. Vaccine Market, By Product Type (Human Vaccine, Animal Vaccine ), By End User - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published by Coherent Market Insights Product code 952836
Published Content info 156 Pages
Delivery time: 2-3 business days
Price
Back to Top
U.S. Vaccine Market, By Product Type (Human Vaccine, Animal Vaccine ), By End User - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
Published: July 20, 2020 Content info: 156 Pages
Description

Vaccines are biologically prepared products, which provide active acquired immunity to diseases such as cholera, polio, rotavirus, smallpox, yellow fever and others. A vaccine comprise an agent resembling to the disease causing microorganism. The vaccines are generally developed from live attenuated or killed forms of the disease causing microorganism, its toxins, or its surface proteins.

Restraints of the U.S. Vaccine Market

Major factors hampering the growth of the U.S. vaccine market during the forecast period constitutes of short functional shelf life of certain vaccines, and high costs.

Key features of the study:

  • This report provides in-depth analysis of the U.S. vaccine market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the U.S. vaccine market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
  • Key companies covered as a part of this study include Sanofi Pasteur, GlaxoSmithKline Plc, Merck & Company Incorporated, Pfizer Incorporated, AstraZeneca plc, and Boehringer Ingelheim.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The U.S. vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the assistive reproductive technology market.

Detailed Segmentation

  • U.S. Vaccine Market, By Product Type:
    • Human Vaccine
      • Pediatric Vaccines
      • Adult & Adolescent Vaccines
      • Other Human Vaccines
    • Animal Vaccine
      • Livestock Vaccines
      • Companion Animal Vaccines
      • Other Animal Vaccines
  • U.S. Vaccine Market, By End User:
    • Hospitals
    • Clinics
    • Vaccination Centers
  • Company Profiles
    • Sanofi Pasteur *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • GlaxoSmithKline Plc
    • Merck & Company Incorporated
    • Pfizer Incorporated
    • AstraZeneca plc
    • Boehringer Ingelheim

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
    • Market Definition and Scope
    • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By End User
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Technological Advancement
    • Regulatory Scenario

4. U.S. Vaccine Market, By Product Type, 2017 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • Human Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Pediatric Vaccines
    • Adult & Adolescent Vaccines
    • Other Human Vaccines
    • Animal Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Livestock Vaccines
    • Companion Animal Vaccines
    • Other Animal Vaccines

5. U.S. Vaccine Market, By End User, 2017 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Vaccination Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)

6. Competitive Landscape

    • Heat Map Analysis
    • Company Profiles
    • Sanofi Pasteur
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • GlaxoSmithKline Plc
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Merck & Company Incorporated
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Pfizer Incorporated
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • AstraZeneca plc
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Boehringer Ingelheim
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

7. Section

    • References
    • Research Methodology
    • About us and Sales Contact
Back to Top